Response to Letter to Editor: "Systemic inflammation and prognosis in HCC: a closer look"
- PMID: 40731179
- DOI: 10.1007/s12072-025-10885-5
Response to Letter to Editor: "Systemic inflammation and prognosis in HCC: a closer look"
Conflict of interest statement
Declarations. Conflict of interest: None of the authors declared a conflict of interest. Ethical approval: The ITA.LI.CA database management conforms to the past and current Italian legislation regarding privacy, and the present study conforms to the ethical guidelines of the Declaration of Helsinki. The study was approved by the Institutional Review Board of the ITA.LI.CA coordinating center, Alma Mater Studiorum University of Bologna, on 15th May 2012 (approval number 99/2012/O/Oss). Informed consent: Written informed consent was obtained from all participants.
References
-
- Rocco A, Sgamato C, Pelizzaro F, et al. Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma. Hepatol Int. 2025. https://doi.org/10.1007/s12072-025-10806-6 - DOI - PubMed
-
- Lin WF, Zhong MF, Zhang YR, et al. Prognostic role of platelet-to-lymphocyte ratio in hepatocellular carcinoma with different BCLC stages: a systematic review and meta-analysis. Gastroenterol Res Pract. 2018;2018:1–10 - DOI
Publication types
LinkOut - more resources
Full Text Sources
